• Maureen Mende has been appointed director of regulatory affairs and quality assurance for Diamics (Novato, California). Most recently Mende served as regulatory affairs group manager for Dade Behring. Diamics is a privately owned company specializing in molecular-based cancer screening.

FoxHollow Technologies (Redwood City, California) said that Michael Ennen, MD, has joined the company as VP, global marketing. Ennen spent the past five years in the healthcare practice of the consulting firm of McKinsey & Company. In addition, FoxHollow reported that Richard Zimmer, senior VP of sales, will be leaving the company at the end of the first quarter of 2007, and the company has initiated search for his replacement. FoxHollow makes minimally invasive devices for the removal of plaque and thrombus for the treatment of peripheral artery disease.

• Tim Ries has accepted a position as vice president of sales for iMedica Corporation (Dallas). Ries formerly worked at Millbrook where he headed up the sales team and worked with many of the executives and developers who are now at iMedica. Ries has also held sales management positions with GE Healthcare and Allscripts. iMedica creates electronic health record solutions.

• Gary Bell will assume the position of chief development officer for MedCath (Charlotte, North Carolina). Most recently, Bell led the effort to acquire more than 40 hospitals in 13states during his 13-year tenure at Health Management Associates. MedCath is a healthcare provider focused on diagnosis and treatment of cardiovascular disease.

No Comments